Skip to content
Tables & Figures

Tables

Table 1.3: Non-Susceptibility of Common Bacterial Isolates From Blood Specimens in HA Hospitals in 2023

Organisms

% Non-susceptible*

Minocycline

Penicillin

Ampicillin

Cloxacillin

Ampicillin-sulbactam

Amoxicillin-clavulanate

Piperacillin-tazobactam

Cefuroxime (parenteral)

Cefotaxime

Ceftazidime

Cefoperazone-sulbactam

Cefepime

Meropenem

Ertapenem

Imipenem

Cotrimoxazole

Erythromycin

Clindamycin

Gentamicin

Amikacin

Ciprofloxacin

Levofloxacin

Vancomycin

Fusidic acid

Rifampicin

Escherichia coli

-

-

79

-

-

30

9.8

34

32

15

-

18

-

0.6

-

-

-

-

26

3.4

-

36

-

-

-

Klebsiella spp.

-

-

99

-

-

23

16

22

18

12

-

11

1.4

1.5

-

-

-

-

7.8

2.0

-

16

-

-

-

Proteus spp.

-

-

74

-

-

35

2.9

28

24

4.0

-

9.5

-

0.0

-

-

-

-

25

2.6

-

48

-

-

-

Pseudomonas aeruginosa

-

-

-

-

-

-

8.5

-

-

5.0

12

3.3

8.6

-

13

-

-

-

-

0.3

7.8

17

-

-

-

Enterobacter spp.†

-

-

-

-

-

96

20

36

25

18

-

5.3

1.4

5.3

-

-

-

-

3.3

1.1

-

5.2

-

-

-

Acinetobacter spp.

15

-

-

-

49

-

57

-

-

28

49

57

61

-

57

22

-

-

30

21

52

57

-

-

-

Enterobacter aerogenes‡

-

-

-

-

-

97

47

49

40

29

-

4.4

0.0

1.8

-

-

-

-

5.1

1.7

-

8.7

-

-

-

Staphylococcus aureus

-

-

-

46

-

-

-

-

-

-

-

-

-

-

-

0.2

23

22

19

-

-

-

0.0

9.2

0.8

Viridans group streptococci

-

16

-

-

-

-

-

-

-

-

-

-

-

-

-

-

29

21

-

-

-

5.4

0.0

-

-

Enterococcus spp.§

-

-

44

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

34

-

-

55

1.9

-

-

Non-susceptible percentages from less than 70% of the total isolates tested for susceptibility to that drug are not reported.

*Non-susceptible is defined as an isolate tested as Intermediate, Resistant to that particular drug.

†Excluding Enterobacter aerogenes

‡Formerly known as Klebsiella aerogenes

§Excluding viridans group streptococci